Clinical trial
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the…
NCT00003325 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003325 |
|---|---|
| Title | Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva |
| Official title | Intraoperative Lymphatic Mapping in Patients With Stage I and II Squamous Carcinoma of the Vulva |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Vulvar Cancer |
| Intervention type | Procedure |
| Interventions | Sentinel lymph node mapping |
| Enrollment | 515 |
| Start date | Dec 1, 1999 |
| Primary completion | Jul 1, 2013 |
| First posted | Jan 27, 2003 |
| Last update posted | May 29, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: